Skip to content

Author

M. Maebeya

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review

Striatin–anaplastic lymphoma kinase (STRN–ALK) is a rare fusion variant in non‐small cell lung cancer (NSCLC), and the efficacy of first‐line lorlatinib for this subgroup is poorly defined. We report a 45‐year‐old treatment‐naïve male with STRN‐ALK‐positive lung adenocarcinoma and symptomatic brain metastases. Followin...

M. Maebeya, S. Tamura, Takeshi Shono et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.